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ABSTRACT Human cytomegalovirus shed in infant urine was isolated and serially
passaged in fibroblasts in the presence or absence of neutralizing antibodies. Com-
parison of the genome sequences of representative viruses Ig-KG-H2 (passed with
antibody) and -KG-B5 (passed without antibody) revealed the presence of several
mutations in each virus.
Human cytomegalovirus (HCMV) replicates poorly when first isolated from clinicalmaterial. However, upon serial passage in fibroblasts, improved replication and
increased release of cell-free virus are conferred by disruptive mutations in the RL13
gene and one or more of the contiguous genes UL128, UL130, and UL131A (1). The latter
mutations disrupt assembly of a pentameric complex on the virion surface that is
important for entry into epithelial and endothelial cells but not fibroblasts (2–6).
In our recent work, replicate fibroblast cultures were infected with HCMV in urine
from a symptomatic congenitally infected infant (7). One lineage (Ig-KG) was passaged
with HCMV-hyperimmune globulin (HIG) (CytoGam) in the culture medium, whereas
the other (-KG) was passaged in the absence of HIG. -KG lost epithelial tropism and
acquired frameshift mutations disrupting RL13 and UL131A, whereas Ig-KG retained
epithelial tropism and was intact in these genes after 22 passages. Long-term genetic
stability of these lineages (and their mutations) was confirmed by isolating represen-
tative viruses by limiting dilution, i.e., Ig-KG-H2 from the Ig-KG passage 22 stock and
-KG-B5 from the -KG passage 13 stock.
Preliminary Ion Torrent and targeted PCR/Sanger sequence analyses that were
focused on protein-coding sequences identified mutations affecting five genes (RL13,
UL100, UL102, UL122, and UL131A) in the parental Ig-KG and -KG stocks that were also
present in Ig-KG-H2 and -KG-B5 (7). Here, we report the complete genome sequence
of Ig-KG-H2 and compare it with that of -KG-B5.
Ig-KG-H2 or -KG-B5 virions were pelleted from culture supernatants by ultracen-
trifugation and treated with DNase I prior to DNA purification by proteinase K digestion,
phenol-chloroform extraction, and ethanol precipitation (7). DNA samples (100 ng)
were sheared acoustically to an approximate size of 450 bp, and sequencing libraries
were processed through seven PCR cycles using the LTP library preparation kit (KAPA
Biosystems, Wilmington, MA, USA), employing NEBNext multiplex oligos for Illumina
(New England Biolabs, Ipswich, MA, USA). Sequencing on an Illumina NextSeq mid-
output 300-cycle cartridge generated 9,614,942 and 10,011,260 paired-end reads of 150
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nucleotides for Ig-KG-H2 and -KG-B5, respectively. A pipeline included in the GRACy
tool (https://github.com/salvocamiolo/GRACy) was used to perform de novo assembly
of the Ig-KG-H2 reads. Briefly, reads that aligned with the Hg38 human reference
sequence (GenBank GCA_000001405.15) using Bowtie 2 v. 2.3.1 (8) (with the end-to-
end flag set) were removed, and sequencing adapters and low-quality reads were
removed using Trim Galore v. 0.4.0 (https://github.com/FelixKrueger/TrimGalore) and
PRINSEQ v. 0.20.4 (9), respectively. The remaining reads were normalized and assem-
bled using SPAdes v. 3.12 (10), and the resulting contigs were ordered in relation to the
HCMV reference strain Merlin genome sequence (GenBank accession number
AY446894.2). Gaps were closed using an overlap-layout-consensus algorithm imple-
mented in GRACy, and the assembly was further refined by visualization in Tablet v.
1.19.09.03 (11) of a read alignment that had been generated using Bowtie 2. All tools
were used with default parameters unless otherwise specified. The Ig-KG-H2 genome
sequence consisted of 236,244 bp (GC content, 57.4%) and was determined at an
average coverage of 4,886 reads/nucleotide. The -KG-B5 reads were aligned to the
resulting Ig-KG-H2 genome sequence using Bowtie 2, and differences present in the
entire population were identified manually using Tablet.
As reported previously (7), -KG-B5 had disruptive mutations in RL13 and UL131A, as
well as a single amino acid substitution in UL122 (Table 1). In contrast, Ig-KG-H2 lacked
disruptive mutations in RL13 and UL128, UL130, or UL131A but contained mutations
resulting in four amino acid substitutions in UL100, two amino acid substitutions in
UL102, and a distinct single amino acid substitution in UL122. Also, Ig-KG-H2 had two
silent mutations in UL57 and UL98. The availability of the genome sequences of
Ig-KG-H2 and -KG-B5 will facilitate studies of the relative importance of these muta-
tions in the adaptation of Ig-KG-H2 to growth in the presence of HIG.
Data availability. The genome sequence of Ig-KG-H2 has been deposited in
GenBank under accession number MN274568. Raw reads are available from the
European Nucleotide Archive with accession numbers ERR3988552 (Ig-KG-H2) and
ERR3988553 (-KG-B5).
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TABLE 1Mutations identified in the Ig-KG-H2 and -KG-B5 genomes
Gene Protein Mutanta Mutation(s)b Consequence
None None -KG-B5c 1-bp deletion (C6372) None




UL57 Single-stranded DNA-binding protein Ig-KG-H2 C89864T substitution Silent
UL98 DNase Ig-KG-H2 C145699T substitution Silent
UL100 Envelope glycoprotein M Ig-KG-H2 C146566G substitution E361D
C146750A and T146751G substitutions S300L
C146794A substitution Q286H
C147608A substitution S15I
UL102 Helicase-primase subunit Ig-KG-H2 C147895G substitution L23V
C148861G substitution L345V
C149640T substitution Silent
UL122 Regulatory protein IE2 -KG-B5 G171290C substitution F384L
Ig-KG-H2 G171315T substitution S376Y
UL131A Envelope protein UL131A -KG-B5 1-bp insertion (T178079) Frameshift after
residue 27
a The virus in which each mutation occurred was identified by comparison with strain Merlin as a representative HCMV strain.
b Coordinates refer to the Ig-KG-H2 genome sequence.
c This is only nominally a mutant, as the mutation represents a difference in the number of nucleotides in a C tract that varies in length among HCMV strains.
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